Advances in the drug clinical trials of neurofibromatosis type Ⅰ-associated plexiform neurofibromas

Jieyi REN; Yihui GU; Qingfeng LI; Zhichao WANG.
Chinese Journal of Plastic Surgery ; (6): 83-87, 2020.
Artículo en Zh | WPRIM | ID: wpr-798831

Documentos relacionados

  1. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
  2. Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?
  3. Case of Symptomatic Dermal Neurofibroma With Microcystic Features.
  4. Global research trends in cutaneous neurofibromas: A bibliometric analysis from 2003 to 2022.
  5. Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.
  6. How to Distinguish Solitary Neurofibroma From Neurofibromatosis Type 1.
  7. Neurofibroma: Case Series with Clinical Features and Recommendations.
  8. Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
  9. Extracranial hypoglossal neurofibroma with a variant ansa cervicalis: a case report.
  10. Deregulated expression of polycomb repressive complex 2 target genes in a NF1 patient with microdeletion generating the RNF135-SUZ12 chimeric gene.